Qalsody Makes MND Treatment Affordable | Australia News

A major breakthrough for motor neurone disease patients: Qalsody, a drug targeting the SOD1 genetic form of ALS, is now available for just $25 a script—down from $28,000. While not a cure, it slows progression and preserves function, offering vital time for those battling this aggressive illness. The move honors Neale Daniher’s legacy, who founded Fight MND in 2014 after his diagnosis, and reflects government commitment, with $40 million pledged to the Neale Daniher MND Clinical Network. This isn’t just a price drop—it’s a lifeline made accessible, igniting hope for patients and families.

Listen in comfort:
Get a d...